OVERVIEW

New and Emerging Agents for the Management of Moderate-to-Severe Atopic Dermatitis in Adults: A Virtual Reality View is organized by Med Learning Group and will be held from Jun 28, 2018 - Jun 28, 2019.

Target Audience:
This activity is intended for US-based dermatologists, allergists/immunologists, and primary healthcare professionals (physicians, nurse practitioners, and physician assistants) involved in the management of adult patients with AD.

Accreditation Statement:
Credit Designation Statement
Med Learning Group designates this enduring activity for a maximum of 1.5 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Nursing Credit Information
Purpose: This program would be beneficial for nurses involved in the care of patients with atopic dermatitis.
Credits: 1.5 ANCC Contact Hour(s)

Program Overview:
This online activity is focused on the team involved in the management and collaborative care of atopic dermatitis in adult patients.

Learning Objectives:
Upon completion of the program, attendees should be able to:
• Review recent pathophysiological findings in AD that have informed the selection of new therapeutic targets.
• Identify best practices for assessing diseases severity and diagnosing moderate-to-severe AD in adult patients.
• Describe the clinical profiles and mechanisms of action of new and emerging agents for the treatment of adults in AD.